Genmab A/S (GMAB) Free cash flow 2023–2025
Genmab A/S (GMAB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$1.1BFY2025 · since FY2023: $1.0B → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | +4.5% |
| FY2024 | $1.1B | +8.0% |
| FY2023 | $1.0B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice